U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07745699) titled 'Fully Remote, Telehealth-based Ketogenic Metabolic Therapy for Long COVID' on July 29.
Brief Summary: The goal of this clinical trial is to learn if a 12-week ketogenic diet program combined with lifestyle strategies (called KMT-LS) is practical and acceptable as a fully remote intervention for adults with Long COVID who also have Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (ME/CFS) and dysautonomia (problems with heart rate, blood pressure, or other automatic body functions).
The main questions it aims to answer are:
Can a ketogenic diet program be successfully delivered entirely from home using online tools and virtual su...